Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

CEO appointment and Board changes

12 May 2022 07:15

RNS Number : 1833L
Plant Health Care PLC
12 May 2022
 

PLANT HEALTH CARE plc

("Plant Health Care" or the "Company")

 

CEO appointment and Board changes

 

Plant Health Care® (AIM: PHC.L), a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce the appointment of a new Chief Executive Officer and consequent changes to the Board.

 

Highlights

 

· Jeff Tweedy, currently the Company's Chief Operating Officer, will be appointed Chief Executive Officer (CEO) with effect from the Annual General Meeting on June 22nd, 2022

· At the same time, Chris Richards, currently CEO, will be appointed Non-Executive Chairman of the Board and Richard Webb, currently Non-Executive Chairman, will step down from the Board. 

 

Chris Richards stepped in as CEO in November 2017, having previously been Chairman since August 2012. By appointing Chris to the role of Non-Executive Chairman, the Company continues to benefit from his deep experience. At the same time, Richard Webb, currently Non-Executive Chairman, will step down from the Board to pursue other interests.

 

Chris Richards, CEO of Plant Health Care said, ‟I am delighted with the appointment of Jeff Tweedy as my successor, in line with our long-established succession plan. Jeff has delivered consistent and exceptional performance as COO and has earned the respect of both internal and external stakeholders. He is the perfect person to lead the company into its exciting next phase of growth. It will be an honour to support Jeff in his new role, where I have no doubt that his energy, commitment and professionalism will deliver continued success for Plant Health Care over the coming years. 

 

"On behalf of the entire Board, I would like to express our most heartfelt thanks to Richard Webb. Richard was instrumental in the early strategic development of the company, especially in working with Dr Zhongmin Wei on the research which has delivered the enormously exciting PREtec product pipeline. As such, Richard has made an incomparable contribution to the Company. We wish him every success in his new endeavours."

 

Background

Jeff Tweedy joined Plant Health Care in October 2017 as Commercial Head for North America, then promoted to Global Head of Commercial in 2020. He was then appointed Chief Operating Officer of Plant Health Care and a member of the Board of Directors in November 2019. Jeff has progressively taken on more responsibilities and discharged them with great success. Over the last 18 months, he has led most of the day-to-day operations of the Company. Under Jeff's leadership, the Company has delivered robust financial performance and successfully brought forward the exceptionally promising PREtec ('Vaccines for Plants') product pipeline. In light of this performance, the Board unanimously agreed to appoint Jeff as Chief Executive Officer of Plant Health Care (CEO), with effect from the end of the Annual General Meeting on June 22nd, 2022.

 

With effect from June 22nd, Jeff Tweedy will be responsible for running the Company. Chris Richards will be available to mentor Jeff and to provide support for corporate development and investor relations.

 

Richard Webb has been a valued member of the Board since 2013 and has made an invaluable contribution to the Company's strategy, especially in supporting the discovery and development of PREtec.

 

About Plant Health Care

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile. Find out more at Vox Markets and the company website: www.planthealthcare.com

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

For further information, please contact:

 

Plant Health Care plc

 

Jeff Hovey, CFO

+1 919 926 1600

Cenkos Securities plc - Nomad and Broker

 

Neil McDonald / Peter Lynch

+44 (0) 20 7391 8900

Vox Markets - Digital Investor Relations

 

Paul Cornelius / Kat Perez

+44 (0) 7866 384707

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAABMRTMTJBBBT
Date   Source Headline
29th Nov 201312:12 pmRNSDirector's Shareholding
25th Nov 20133:15 pmRNSDivestment of non-core subsidiary
18th Oct 20135:00 pmRNSTR-1 Notification of Major Interest in Shares
30th Sep 20135:00 pmRNSTotal Voting Rights
23rd Sep 201310:30 amRNSDirector/PDMR Shareholding
19th Sep 20137:00 amRNSAppointment of Adviser
18th Sep 20133:15 pmRNSDirector/PDMR Shareholding
16th Sep 20137:03 amRNSDirectorate Change
16th Sep 20137:00 amRNSHalf Yearly Report
19th Aug 20132:30 pmRNSBlocklisting Interim Review
30th Jul 20137:01 amRNSUpdate on Harpin
30th Jul 20137:00 amRNSPHC announces plans for Harpin seed treatment
22nd Jul 201311:00 amRNSPHC hires Glen Donald as VP Business Development
19th Jul 20137:00 amRNSHead Office Relocation,Research Facility Expansion
15th Jul 20135:15 pmRNSDirector/PDMR Shareholding
5th Jul 20137:00 amRNSUpdate on CISX Listing
3rd Jul 20137:00 amRNSNew Long-Term Incentive Plan and Grant of Awards
7th Jun 20134:15 pmRNSDirectorate Change
31st May 201311:30 amRNSTotal Voting Rights
21st May 201312:00 pmRNSHarpin Granted Federal Registration in Mexico
10th May 20134:45 pmRNSDirector/PDMR Shareholding
9th May 20131:20 pmRNSDirectorate Change
9th May 20131:20 pmRNSResult of AGM
7th May 201310:00 amRNSDirector/PDMR Shareholding
3rd May 20137:00 amRNSDirector/PDMR Shareholding
1st May 20137:00 amRNSDirector/PDMR Shareholding
1st May 20137:00 amRNSTotal Voting Rights
25th Apr 20137:00 amRNSPHC and Arysta LifeScience sign license agreement
19th Apr 20133:30 pmRNSTR-1 Notification of Major Interest in Shares
18th Apr 20133:33 pmRNSTR-1 Notification of Major Interest in Shares
18th Apr 20133:31 pmRNSTR-1 Notification of Major Interest in Shares
18th Apr 20133:31 pmRNSTR-1 Notification of Major Interest in Shares
16th Apr 20138:23 amRNSRe. Investment
15th Apr 20131:30 pmRNSResult of General Meeting
8th Apr 20135:45 pmRNSPublication of Annual Report and Notice of AGM
2nd Apr 20137:00 amRNSConfirmation of Board Changes
27th Mar 20137:00 amRNSPosting of Circular to Shareholders
26th Mar 20134:19 pmRNSBoard Changes
26th Mar 20134:19 pmRNSPlacing and Subscription
26th Mar 20134:18 pmRNSFinal Results
20th Mar 201311:35 amRNSPHC reaches milestone agreement with Germains
11th Mar 20137:00 amRNSMarket Update
19th Feb 20135:45 pmRNSBlock Listing Six-Monthly Return
24th Jan 20139:30 amRNSHarpin field trials results
18th Jan 20135:00 pmRNSNotification of Major Interest in Shares
10th Jan 201312:45 pmRNSTrading Update
31st Dec 201212:25 pmRNSTotal Voting Rights
30th Nov 201211:45 amRNSTotal Voting Rights
2nd Nov 201212:15 pmRNSNotification of Major Interest in Shares
23rd Oct 20127:00 amRNSNotification of Major Interest in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.